Jump to content

8-Phenyltheophylline: Difference between revisions

Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').
Added doi. Added the cs1 style template to denote Vancouver ("vanc") citation style, because references contain "vauthors" attribute to specify the list of authors.
 
(23 intermediate revisions by 20 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{cs1 config|name-list-style=vanc}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 426589897
| verifiedrevid =
| IUPAC_name = 8-phenyl-1,3-dimethyl-7''H''-purine-2,6-dione
| IUPAC_name = 8--1,3-dimethyl-7''H''-purine-2,6-dione
| image = 8-Phenyltheophylline.png
| image = 8-Phenyltheophylline.
| alt = Skeletal formula of 8-phenyltheophylline
| image2 = 8-Phenyltheophylline 3D ball.png
| alt2 = Ball-and-stick model of the 8-phenyltheophylline molecule


<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename =
| pregnancy_category =
| pregnancy_category =
| legal_status =
| legal_status =
| routes_of_administration =
| routes_of_administration =


<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| bioavailability =
| metabolism =
| metabolism =
| excretion =
| excretion =


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = <!-- blanked - oldvalue: 961-45-5 -->
| ATC_prefix =
| =
| UNII_Ref = {{fdacite|correct|FDA}}
| ATC_suffix =
| UNII = E6M543P3BL
| ATC_prefix = None
| ATC_suffix =
| PubChem = 1922
| PubChem = 1922
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1846
| ChemSpiderID = 1846
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL_Ref = {{ebicite||EBI}}
| ChEMBL = 62350
| ChEMBL = 62350


<!--Chemical data-->
<!--Chemical data-->
| C=13 | H=12 | N=4 | O=2
| C=13 | H=12 | N=4 | O=2
| smiles = Cn3c(=O)c2nc(c1ccccc1)[nH]c2n(C)c3=O
| molecular_weight = 256.259 g/mol
| smiles = c3ccccc3-c(nc12)nc2n(C)c(=O)n(C)c1=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H12N4O2/c1-16-11-9(12(18)17(2)13(16)19)14-10(15-11)8-6-4-3-5-7-8/h3-7H,1-2H3,(H,14,15)
| StdInChI = 1S/C13H12N4O2/c1-16-11-9(12(18)17(2)13(16)19)14-10(15-11)8-6-4-3-5-7-8/h3-7H,1-2H3,(H,14,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PJFMAVHETLRJHJ-UHFFFAOYSA-N
| StdInChIKey = PJFMAVHETLRJHJ-UHFFFAOYSA-N
| melting_point =
| melting_point =
| melting_high =
| melting_high =
}}
}}


'''8-Phenyltheophylline''' ('''8-Phenyl-1,3-dimethylxanthine''', '''8-PT''') is a [[drug]] derived from the [[xanthine]] family which acts as a [[potency (pharmacology)|potent]] and [[binding selectivity|selective]] [[receptor antagonist|antagonist]] for the [[adenosine receptor]]s [[Adenosine A1 receptor|A<sub>1</sub>]] and [[Adenosine A2A receptor|A<sub>2A</sub>]], but unlike other xanthine derivatives has virtually no activity as a [[phosphodiesterase inhibitor]].<ref name="pmid6844374">{{cite journal |author=Scotini E, Carpenedo F, Fassina G |title=New derivatives of methyl-xanthines: effect of thiocaffeine thiotheophylline and 8-phenyltheophylline on lipolysis and on phosphodiesterase activities |journal=Pharmacological Research Communications |volume=15 |issue=2 |pages=131–43 |year=1983 |month=February |pmid=6844374 |doi= |url=}}</ref><ref name="pmid7664866">{{cite journal |author=Rabe KF, Magnussen H, Dent G |title=Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants |journal=The European Respiratory Journal : Official Journal of the European Society for Clinical Respiratory Physiology |volume=8 |issue=4 |pages=637–42 |year=1995 |month=April |pmid=7664866 |doi= |url=}}</ref><ref name="pmid2395111">{{cite journal |author=Howell LL, Morse WH, Spealman RD |title=Respiratory effects of xanthines and adenosine analogs in rhesus monkeys |journal=The Journal of Pharmacology and Experimental Therapeutics |volume=254 |issue=3 |pages=786–91 |year=1990 |month=September |pmid=2395111 |doi= |url=}}</ref> It has [[stimulant]] effects in animals with similar potency to [[caffeine]].<ref name="pmid3133696">{{cite journal |author=Spealman RD |title=Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism |journal=Psychopharmacology |volume=95 |issue=1 |pages=19–24 |year=1988 |pmid=3133696 |doi= |url=}}</ref> Coincidentally 8-phenyltheophylline has also been found to be a potent and selective inhibitor of the liver enzyme [[CYP1A2]] which makes it likely to cause interactions with other drugs which are normally metabolised by CYP1A2.<ref name="pmid11465391">{{cite journal |author=Murray S, Odupitan AO, Murray BP, Boobis AR, Edwards RJ |title=Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline |journal=Xenobiotica |volume=31 |issue=3 |pages=135–51 |year=2001 |month=March |pmid=11465391 |doi=10.1080/00498250110043292 |url=}}</ref>
'''8-Phenyltheophylline''' ('''8--1,3-dimethylxanthine''', '''8-PT''') is a [[drug]] derived from the [[xanthine]] family which acts as a [[potency (pharmacology)|potent]] and [[binding selectivity|selective]] [[receptor antagonist|antagonist]] for the [[adenosine receptor]]s [[Adenosine A1 receptor|A<sub>1</sub>]] and [[Adenosine A2A receptor|A<sub>2A</sub>]], but unlike other xanthine derivatives has virtually no activity as a [[phosphodiesterase inhibitor]].<ref name="pmid6844374">{{cite journal |=Scotini E, Carpenedo F, Fassina G |title=New derivatives of methyl-xanthines: effect of thiocaffeine thiotheophylline and 8-phenyltheophylline on lipolysis and on phosphodiesterase activities |journal=Pharmacological Research Communications |volume=15 |issue=2 |pages=131–43 | =February |pmid=6844374 |doi =}}</ref><ref name="pmid7664866">{{cite journal |=Rabe KF, Magnussen H, Dent G |title=Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants |journal=The European Respiratory Journal |volume=8 |issue=4 |pages=637–42 | =April |doi= |=}}</ref><ref name="pmid2395111">{{cite journal |=Howell LL, Morse WH, Spealman RD |title=Respiratory effects of xanthines and adenosine analogs in rhesus monkeys |journal=The Journal of Pharmacology and Experimental Therapeutics |volume=254 |issue=3 |pages=786–91 | =September |pmid = }}</ref> It has [[stimulant]] effects in animals with similar potency to [[caffeine]].<ref name="pmid3133696">{{cite journal |=Spealman RD |title=Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism |journal=Psychopharmacology |volume=95 |issue=1 |pages=19–24 |year=1988 |pmid=3133696 |doi= |=}}</ref> Coincidentally 8-phenyltheophylline has also been found to be a potent and selective inhibitor of the liver enzyme [[CYP1A2]] which makes it likely to cause interactions with other drugs which are normally metabolised by CYP1A2.<ref name="pmid11465391">{{cite journal |=Murray S, Odupitan AO, Murray BP, Boobis AR, Edwards RJ |title=Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline |journal=Xenobiotica |volume=31 |issue=3 |pages=135–51 | =March |pmid=11465391 |doi=10.1080/00498250110043292 |=}}</ref>


== See also ==
== See also ==
Line 44: Line 52:
* [[8-Cyclopentyltheophylline]]
* [[8-Cyclopentyltheophylline]]
* [[DPCPX]]
* [[DPCPX]]
* [[DMPX]]
* [[Xanthine]]
* [[Xanthine]]


Line 50: Line 59:


{{Adenosinergics}}
{{Adenosinergics}}
{{Stimulants}}


{{DEFAULTSORT:Phenyltheophylline, 8-}}
{{DEFAULTSORT:Phenyltheophylline, 8-}}
[[Category:Adenosine antagonists]]
[[Category:Xanthines]]


[[Category:Adenosine antagonists]]
[[Category:Xanthines]]


{{nervous-system-drug-stub}}
{{nervous-system-drug-stub}}